AUROBINDO PHARMA
Back to Balance Sheet
|
AUROBINDO PHARMA Last 5 Year Total Non-Current Assets History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Non-Current Assets | ₹21,330 Cr | ₹19,653 Cr | ₹17,667 Cr | ₹15,510 Cr | ₹13,578 Cr |
What is the latest Total Non-Current Assets ratio of AUROBINDO PHARMA ?
| Year | Total Non-Current Assets |
|---|---|
| Mar2025 | ₹21,330 Cr |
| Mar2024 | ₹19,653 Cr |
| Mar2023 | ₹17,667 Cr |
| Mar2022 | ₹15,510 Cr |
| Mar2021 | ₹13,578 Cr |
How is Total Non-Current Assets of AUROBINDO PHARMA Trending?
| Years | Total Non-Current Assets | % Change | |
|---|---|---|---|
| Mar2025 | ₹21,330 Cr | 8.53 | |
| Mar2024 | ₹19,653 Cr | 11.24 | |
| Mar2023 | ₹17,667 Cr | 13.90 | |
| Mar2022 | ₹15,510 Cr | 14.23 | |
| Mar2021 | ₹13,578 Cr | - | |
Compare Total Non-Current Assets of peers of AUROBINDO PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| AUROBINDO PHARMA | ₹90,875.8 Cr | 2.9% | 1.5% | 42.4% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹477,312.0 Cr | 3.1% | 7.2% | 18.3% | Stock Analytics | |
| DIVIS LABORATORIES | ₹213,879.0 Cr | 8.2% | 19.8% | 17.2% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹194,094.0 Cr | -1.8% | 4.9% | 37.2% | Stock Analytics | |
| CIPLA | ₹118,992.0 Cr | 3.9% | 0.6% | 0% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹95,787.4 Cr | -0.7% | -14.6% | -8.4% | Stock Analytics | |
AUROBINDO PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| AUROBINDO PHARMA | 2.9% |
1.5% |
42.4% |
| SENSEX | 2.7% |
1.5% |
-5.6% |
You may also like the below Video Courses